Solazyme Inc. (SZYM) Jumps 5.28% on February 12

Equities Staff |

Solazyme Inc. (SZYM) was among the biggest gainers on the Russell 2000 for Friday February 12 as the stock popped 5.28% to $1.47, representing a gain of $0.0739 per share. Some 162,750 shares traded hands on 664 trades, compared with an average daily volume of 512,583 shares out of a total float of 80.54 million. The stock opened at $1.41 and traded with an intraday range of $1.48 to $1.39.

After today's gains, Solazyme Inc. reached a market cap of $118.71 million. Solazyme Inc. has had a trading range between $4.74 and $1.18 over the last year, and it had a 50-day SMA of $2.14 and a 200-day SMA of $2.77.

Solazyme Inc, along with its subsidiaries, is engaged in providing renewable oils and other bioproducts. It commercializes its products into target markets such as chemicals and fuels, nutrition, and skin and personal care.

Solazyme Inc. is based out of South San Francisco, CA and has some 266 employees. Its CEO is Jonathan S. Wolfson.

For a complete fundamental analysis analysis of Solazyme Inc., check out’s Stock Valuation Analysis report for SZYM. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets


Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…